Question 1

What is Paris-Trousseau thrombocytopenia?

Accepted Answer

Paris-Trousseau thrombocytopenia (TCPT) is a genetic condition known as a contiguous gene syndrome. This means that a group of genes in a specific region is affected, which leads to certain clinical features. People with this condition often experience a mild bleeding tendency and have a lower than normal number of platelets (thrombocytopenia).

In addition to bleeding issues, there may be distinctive facial features (dysmorphic facies) and unusual findings in platelets such as giant alpha-granules. There can also be problems with the development of the cells that make platelets (dysmegakaryopoiesis).

Question 2

What are the symptoms of Paris-Trousseau thrombocytopenia?

Accepted Answer

Common signs of this condition include a mild tendency to bleed and variable levels of thrombocytopenia, meaning that the platelet count can differ among affected people. Some may also show unique facial features and abnormalities in the size and appearance of their platelets.

Question 3

What causes Paris-Trousseau thrombocytopenia?

Accepted Answer

Paris-Trousseau thrombocytopenia is caused by a change in a group of genes located close together, which is why it is called a contiguous gene syndrome. The condition is linked to genes such as TCPT. This genetic change affects how platelets form and function, leading to the symptoms observed.

Question 4

How is Paris-Trousseau thrombocytopenia inherited?

Accepted Answer

Paris-Trousseau thrombocytopenia follows an sporadic (occurs randomly) inheritance pattern.

Question 5

How rare is Paris-Trousseau thrombocytopenia?

Accepted Answer

Paris-Trousseau thrombocytopenia is classified as very rare. The estimated prevalence is approximately <1 in 1,000,000. Because rare disease data can be limited, actual numbers may differ from published estimates.

Question 6

How is Paris-Trousseau thrombocytopenia diagnosed?

Accepted Answer

Information about diagnosis is currently limited for this condition.

Question 7

Are there treatments for Paris-Trousseau thrombocytopenia?

Accepted Answer

Information about treatment is currently limited for this condition.

Question 8

What complications can arise from Paris-Trousseau thrombocytopenia?

Accepted Answer

People with Paris-Trousseau thrombocytopenia may experience a mild bleeding tendency due to low platelet counts. This can lead to easy bruising or prolonged bleeding from cuts. It's important to monitor for any unusual bleeding, as it can vary from person to person.

Question 9

How does Paris-Trousseau thrombocytopenia affect daily life?

Accepted Answer

Living with Paris-Trousseau thrombocytopenia may mean being cautious about activities that could lead to injury or bleeding. Families might need to adapt certain activities to ensure safety, like avoiding contact sports. Regular check-ups with a healthcare provider can help manage the condition effectively.

Question 10

Are there specific facial features associated with Paris-Trousseau thrombocytopenia?

Accepted Answer

Yes, individuals with Paris-Trousseau thrombocytopenia may have distinctive facial features, known as dysmorphic facies. These features can vary among individuals but are part of the condition's characteristics. It's important for families to understand that these features are a part of the syndrome.

Question 11

What should families consider regarding planning for children if one parent has Paris-Trousseau thrombocytopenia?

Accepted Answer

Families considering having children should be aware that Paris-Trousseau thrombocytopenia is a genetic condition. Genetic counseling can provide information about the chances of passing the condition to children. It's a good idea to discuss these concerns with a healthcare provider who understands the condition.

Organ System	Phenotype Count	Example Features
Blood and immune system	3	Abnormal bleeding tendency (abnormal bleeding), Prolonged bleeding time, Low platelet count (thrombocytopenia)

Kisho

Paris-Trousseau thrombocytopenia

Overview

Clinical Presentation

Prognosis

Research Landscape

Recent Publications

Medical References

External Resources

OMIM

Orphanet

GARD

Questions for Your Care Team

Questions for Your Care Team

FAQ

Frequently Asked Questions

Explore clinical features

Latest News & Developments

Successful vaginal delivery in very severe malarial thrombocytopenia: a case report.

Tirofiban-Associated Profound Thrombocytopenia in a Patient With Glucose-6-Phosphate Dehydrogenase Deficiency Undergoing Primary Percutaneous Coronary Intervention: A Case Report.

Effects of Platelet Transfusion on Sepsis Associated Thrombocytopenia (SAT): A Multicenter Retrospective Chart Review.

Paris-Trousseau thrombocytopenia

Overview

Clinical Presentation

Prognosis

Research Landscape

Recent Publications

Medical References

External Resources

OMIM

Orphanet

GARD

Related Diseases

Questions for Your Care Team

Questions for Your Care Team

FAQ

Frequently Asked Questions

What is Paris-Trousseau thrombocytopenia?

What are the symptoms of Paris-Trousseau thrombocytopenia?

What causes Paris-Trousseau thrombocytopenia?

How is Paris-Trousseau thrombocytopenia inherited?

How rare is Paris-Trousseau thrombocytopenia?

How is Paris-Trousseau thrombocytopenia diagnosed?

Are there treatments for Paris-Trousseau thrombocytopenia?

What complications can arise from Paris-Trousseau thrombocytopenia?

How does Paris-Trousseau thrombocytopenia affect daily life?

Are there specific facial features associated with Paris-Trousseau thrombocytopenia?

What should families consider regarding planning for children if one parent has Paris-Trousseau thrombocytopenia?

Explore clinical features

Latest News & Developments

Successful vaginal delivery in very severe malarial thrombocytopenia: a case report.

Tirofiban-Associated Profound Thrombocytopenia in a Patient With Glucose-6-Phosphate Dehydrogenase Deficiency Undergoing Primary Percutaneous Coronary Intervention: A Case Report.

Effects of Platelet Transfusion on Sepsis Associated Thrombocytopenia (SAT): A Multicenter Retrospective Chart Review.